research Archives - Pharmaphorum

Web and mobile technologies for health economics modelling

April 3, 2017

Digital apps are more agile than longstanding solutions and allow tailored interrogation of data.

Web and mobile technologies for health economics modelling

https://pharmaphorum.com/views-and-analysis/web-mobile-technologies-health-economics-modelling/

Patient-centric trials – dream or reality?

March 16, 2017

Many pharma companies claim to put patients at the heart of research, but how many live up to these expectations?

Patient-centric trials – dream or reality?

https://pharmaphorum.com/views-and-analysis/patient-centric-trials-dream-reality/

Collaboration the key to success in respiratory research

January 11, 2017

Lung research needs support as fifth of UK diagnosed with respiratory condition.

Collaboration the key to success in respiratory research

https://pharmaphorum.com/views-and-analysis/collaboration-key-success-respiratory-research/

Access and elimination: the future of DAAs in hepatitis C

January 4, 2017

How direct-acting antivirals are transforming treatment of hepatitis C.

Access and elimination: the future of DAAs in hepatitis C

https://pharmaphorum.com/views-and-analysis/access-elimination-future-daas-hepatitis-c/

UK science funding uncertain after Brexit vote

June 28, 2016

UK government says funding will continue until Brexit is resolved.

UK science funding uncertain after Brexit vote

https://pharmaphorum.com/news/uk-science-funding-uncertain-following-brexit-vote/

Trending

research

Patient-centric trials – dream or reality?

Collaboration the key to success in respiratory research

Access and elimination: the future of DAAs in hepatitis C

UK science funding uncertain after Brexit vote

CDD for Biologics Summit 2017

Neoantigen Summit 2017

ICI Summit Europe 2017

2nd Annual Cancer Immunotherapy Summit

6th International GMP, GCP & Quality Control Summit

Inhalation and Respiratory Drug Products Summit

NHS seal of approval for gestational diabetes app

Sanofi showcases eczema data ahead of EU decision

COPD triple approved, can GSK maximise its revenues?

Teva sells women’s health division to tackle $35bn debts

EU regulators reject Santhera’s Raxone for DMD

What is ‘affordable’? The reality of the PPRS

UK biotech round-up: Autolus joins CAR-T race, Horizon’s new CRISPR tech, Allergy Therapeutics’ grass gambit

Get real: virtual reality for healthcare comes of age

Unstable and unpredictable? The reality of the PPRS

Clinical trial summaries for lay people – unpicking the guidance

Search

Advanced Search

Trending

research